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Brief CommunicationsPediatric Application of the Thoratec CentriMag BiVAD as a Bridge
to Heart Transplantation
Yasutaka Hirata, MD,a Kevin Charette, CCP,a Ralph S. Mosca, MD,a Jan M. Quaegebeur, MD,a and Jonathan M. Chen, MD,b
New York, NYThe Thoratec CentriMag ventricular assist device (VAD)
(Thoratec Corporation Pleasanton, Calif) (Figure 1) is a cen-
trifugal pump designed for extracorporeal support that
operates without mechanical bearings or seals. Although
extracorporeal membrane oxygenation (ECMO) provides
cardiac and respiratory support in a rapid manner for the pe-
diatric patient population, it offers only short-term support
with an increase in complications beyond the second
week. The CentriMag system has advantages over other
systems: the pumps have a low priming volume and low re-
quirements for heparin and hemolysis. We report three suc-
cessful applications of the CentriMag BiVAD as a bridge to
pediatric heart transplantation.
CLINICAL SUMMARIES
PATIENT 1. A 7-year-old previously healthy boy with a 10-
day history of abdominal symptoms was brought to the
emergency department initially stable, but his condition de-
teriorated and later necessitated intubation and full cardiac
support; his oxygen saturation decreased to 40%. Echocar-
diographic analysis revealed severely decreased left ventric-
ular function. The heart arrested in the operating room
before incision and cardiopulmonary bypass was instituted
as an emergency measure. A malleable 28F lighthouse tip
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through an incision along the costal margin at a point just in-
ferior to the approximate site of the left ventricular apex.
Two concentric purse-string sutures of 3–0 Prolene polypro-
pylene (Ethicon, Inc, Somerville, NJ) supported with bovine
pericardial pledgets were placed around the left ventricular
apex, and the inflow cannula was placed into the left ventri-
cle. Two 14F Biomedicus cannulas (Biomedicus, Inc, Eden
Prairie, Minn) were similarly placed through two incisions
along the epigastrium and inserted into the ascending aorta
and main pulmonary artery. A 24F malleable lighthouse
tip cannula was placed through an incision along the right
thoracic wall, and the inflow cannula was placed into the
right atrium, directed toward the inferior vena cava. Heparin
was started at 24 hours to maintain an activated clotting time
of 160 to 180 seconds. Because of pulmonary edema and de-
saturation, an oxygenator was inserted in-line with the right
VAD outflow and was removed after 24 hours once his
FIGURE 1. CentriMag pump.urgery c November 2008
Brief CommunicationsTABLE 1. Clinical summary of the 3 patients
Patient 1 Patient 2 Patient 3
Body weight (kg) 32 39.8 10.2
LVAD flow (mL/min) 1.9–2.1 3.0–3.1 0.9–1.0
RVAD flow (mL/min) 1.9–2.1 3.0–3.1 0.8–1.0
Cannulas
LVAD inflow 28F malleable lighthouse tip 28F malleable lighthouse tip 22F malleable lighthouse tip
LVAD outflow 14F Biomedicus 14F Biomedicus 12F Biomedicus
RVAD inflow 24F malleable lighthouse tip 28F malleable lighthouse tip 22F malleable lighthouse tip
RVAD outflow 14F Biomedicus 14F Biomedicus 12F Biomedicus
Transplantation 4 d 3 d 8 h
Outcome Alive Alive Aliveoxygenation had improved with diuresis. He underwent suc-
cessful heart transplantation 4 days later.
PATIENT 2. A 10-year-old boy with history of dilated car-
diomyopathy underwent CentriMag BiVAD implantation
and successful heart transplantation 3 days later.
PATIENT 3. A 3-year-old boy with a history of hereditary
cardiomyopathy underwent CentriMag BiVAD implanta-
tion. At 24 hours postoperatively he was noted to have
a small amount of thrombus in the inflow tubing to the de-
vice and thus had his left-sided pump exchanged at the bed-
side. He underwent successful transplantation 8 hours later.
Table 1 shows the clinical summary of the patients.
DISCUSSION
Although ECMO is still the most common form of me-
chanical support used for infants and young children, data
from several institutions suggest ECMO is effective in
bridging only half of the eligible children to heart transplan-
tation.1-3 Complications such as multiorgan failure, sepsis,
and thromboembolism continue to limit ECMO survival to
3 or 4 weeks. The CentriMag BiVAD is technically easy
to implant, uses any commercially available inflow or out-
flow cannulas, and flows between 200 mL/min and 8 L/
min. The pump also allows both the potential for extubation
and the possibility of including an oxygenator in-line with
the right-sided device if necessary, as in our first case.
We have noted several salient points when implanting the
CentriMag VAD in children as opposed to adults. First, be-
cause of the often very lateral location of the left ventricular
apex and the acute angle of the costal margin in children, it is
most useful to insert the inflow cannulas through the intercos-
tal spaces with a short subcutaneous tunnel.The Journal of Thoracic and CaSecond, because the hearts of these children seem to dilate
disproportionately to the size of the great vessels, often the
outflow cannulas must traverse a broad angle (and long dis-
tance) over the shoulder of the right ventricle before being
inserted into the great vessels (which are small) at a nearly
90 angle. It is therefore important not to insert the cannula
too far, inasmuch as it will abut the back wall of the great
vessel and cause outflow resistance.
Finally, because of the lower flows required with smaller
children, an aggressive anticoagulation scheme is suggested,
with the commencement of heparin therapy soon after the
implantation. Additionally, the use of heparin-coated con-
nectors and tapered tubing, while untested, seems intuitively
logical. We also run below full flow in smaller patients so as
to decrease the likelihood of obliteration of the left ventric-
ular cavity and air entrainment.
CONCLUSION
We report the successful use of the CentriMag BiVAD in
3 children bridged to transplantation. This clinical indication
awaits further application in this age group to better define
the possibility of longer term support.
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